We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+13.49%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.34B
AUM Growth
-$346M
(-9.4%)
Cap. Flow
-$728M
Cap. Flow
% of AUM
-21.78%
Top 10 Holdings %
Top 10 Hldgs %
68.3%
Holding
475
New
106
Increased
41
Reduced
44
Closed
201
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$447M |
| 2 |
CYBR
CyberArk
CYBR
|
+$424M |
| 3 |
GTLS
Chart Industries
GTLS
|
+$243M |
| 4 |
IPG
Interpublic Group of Companies
IPG
|
+$96.3M |
| 5 |
COOP
Mr. Cooper
COOP
|
+$67.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$288M |
| 2 |
SKX
Skechers
SKX
|
+$227M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
+$220M |
| 4 |
CHX
ChampionX
CHX
|
+$187M |
| 5 |
ANSS
Ansys
ANSS
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.6% |
| 2 | Industrials | 16.01% |
| 3 | Healthcare | 15.52% |
| 4 | Communication Services | 12.09% |
| 5 | Financials | 10.18% |
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2025 Portfolio in Review
As of Q3 2025, UBS O'Connor held 475 positions worth $3.34B, down 9.4% from $3.69B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
UBS O'Connor withdrew a net $728M in Q3 2025, closing 201 positions and reducing 44 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $288M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, UBS O'Connor opened a new position in Verona Pharma worth $457M.
- UBS O'Connor's largest Q3 2025 buy was Verona Pharma: 4,283,462 shares worth $457M.
- UBS O'Connor added most to Interpublic Group of Companies in Q3 2025, an estimated $96.3M increase.
- UBS O'Connor's biggest Q3 2025 reduction was Kellanova, cutting an estimated $110M.
- UBS O'Connor fully exited Walgreens Boots Alliance in Q3 2025, selling an estimated $288M.
- UBS O'Connor's ten largest holdings make up 68% of its $3.34B portfolio in Q3 2025.
- UBS O'Connor opened 106 new positions and closed 201 in Q3 2025.
- UBS O'Connor's portfolio value fell 9.4% quarter-over-quarter to $3.34B.
Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.